FDA alerts providers to infusion pump danger

The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson CareFusion 303 Inc. recalled the Alaris Infusion Pump System and Modules in February due to software and other errors that can delay, speed or interrupt the infusion of medications and other fluids to patients. According to FDA, consumers should follow the manufacturer’s recommended actions to help mitigate the potential risk of errors until the software issues have been remediated. Health care providers may report associated adverse reactions or quality problems to FDA’s MedWatch reporting program.
Related News Articles
Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Blog
Read about the 2025 Quest for Quality Prize winner and finalist — and apply for the 2026 awardEach day, health care professionals across the U.S. leverage…
Perspective
Hospitals and health systems across the country vary in size, as well as the types of services and specialties they offer. They also offer many different…
Headline
The AHA Aug. 7 launched a new webpage, Reducing Disparities in Health Outcomes, featuring new and familiar resources for members and their communities. As part…
Headline
Nell Buhlman, chief administrative officer and head of strategy at Press Ganey, and Chris DeRienzo, M.D., AHA chief physician executive, explore the data-…